ReNeuron

ReNeuron is a company developing proprietary stem cell-based exosome technologies. Their research and development efforts are centered around utilizing exosomes, small vesicles released by cells, derived from neural cell lines, for treating conditions like stroke, retinal diseases, and Huntington’s disease.

CEO

Iain Ross

Sub segment

Therapeutics

Location

Bridgend, UK

Related companies

Rosetta Capital
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.